Brochure | May 26, 2022

Mammalian Cell Culture Manufacturing

Source: Grifols

CHIRON is a Contract Development and Manufacturing Organization (CDMO) based in the San Francisco Bay Area, specializing in mammalian cell culture manufacturing. With over 30 years of cGMP manufacturing experience, CHIRON offers a state-of-the-art facility designed to accommodate future expansion and equipment needs. They provide clinical and commercial manufacturing services, with flexible options to meet client requirements and utilize client-specific cell lines and processes.

One of the key advantages of working with CHIRON is their collaborative approach, offering innovative ideas and solutions to overcome project challenges. They have an in-house Quality Team and a successful history of regulatory inspections, ensuring compliance with regulatory standards.

CHIRON's capabilities include the use of 10L, 200L, and 1,000L Single-Use Bioreactors for efficient production. They support early to late-stage clinical and commercial production and offer services such as analytical assay development, qualification, and validation. Their pilot plant enables process development, scale-up, and material production. Additionally, CHIRON provides protein engineering and stable cell line creation.

The company emphasizes efficient technology transfer, with knowledgeable technical experts facilitating the smooth transition of processes. Their manufacturing staff is trained and experienced in cGMP production. CHIRON ensures timely communication and reliable project execution throughout the entire process.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online